Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 May;29(5):1293-1302.
doi: 10.1111/ene.15264. Epub 2022 Feb 14.

Repetitive transcranial magnetic stimulation for patients with functional paralysis: a randomized controlled study

Affiliations
Randomized Controlled Trial

Repetitive transcranial magnetic stimulation for patients with functional paralysis: a randomized controlled study

Nathalie Chastan et al. Eur J Neurol. 2022 May.

Abstract

Background and purpose: Repetitive transcranial magnetic stimulation (rTMS) has been proposed to treat functional neurological disorders. Here, the aim was to assess the efficacy of rTMS to treat functional paralysis in a controlled randomized trial.

Methods: Patients received two sessions of active or sham 0.25 Hz rTMS (60 stimuli each), with a 1-day interval, applied over the motor cortex contralateral to the paralysis. The primary outcome was the number of patients with an increase in motor score between baseline and after the second rTMS session, rated by two investigators blinded to the treatment allocation. Secondary outcomes were changes in global and fine motor scores between groups after rTMS, and the occurrence of adverse events.

Results: Sixty-two patients (46 female; mean [SD] age, 35.2 [13.9] years) were enrolled and randomized. Thirteen out of 32 (41%) and 11/30 (37%) patients had increased motor strength after active or sham rTMS, respectively (p = 0.80). Changes in both global and fine motor scores after rTMS relative to baseline were also not significantly different between treatment groups (median difference in the global motor score 0.62 [0.83] and 0.37 [0.61], and in the fine motor scores 0.12 [0.18] and 0.08 [0.11], in active and sham rTMS groups, respectively; p = 0.14). Six serious adverse events, consisting of three cephalalgia in the active group and two cephalalgia and one asthenia in the sham group, were observed.

Conclusions: Two sessions of sham or active low frequency rTMS were effective to improve functional paralysis, suggesting a placebo effect of this non-invasive brain stimulation technique.

Keywords: clinical trials; controlled; functional motor signs; randomized; transcranial magnetic stimulation.

PubMed Disclaimer

References

REFERENCES

    1. Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?-The diagnoses made in 3781 new patients. Clin Neurol Neurosurg. 2010;112(9):747-751. doi:10.1016/j.clineuro.2010.05.011
    1. Stone J, Carson A, Duncan R, et al. Symptoms “unexplained by organic disease” in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132(10):2878-2888. doi:10.1093/brain/awp220
    1. Carson AJ, Stone J, Hansen CH, et al. Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. J Neurol Neurosurg Psychiatry. 2015;86(3):295-301. doi:10.1136/jnnp-2014-308234
    1. Stone J, Sharpe M, Rothwell PM, Warlow CP. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2003;74(5):591-596. doi:10.1136/jnnp.74.5.591
    1. Gelauff JM, Carson A, Ludwig L, Tijssen MAJ, Stone J. The prognosis of functional limb weakness: a 14-year case-control study. Brain. 2019;142(7):2137-2148. doi:10.1093/brain/awz138

Publication types

LinkOut - more resources